Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

1.

Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism.

Dixit D, Ghildiyal R, Anto NP, Sen E.

Cell Death Dis. 2014 May 8;5:e1212. doi: 10.1038/cddis.2014.179.

PMID:
24810048
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Oral cancer cells may rewire alternative metabolic pathways to survive from siRNA silencing of metabolic enzymes.

Zhang M, Chai YD, Brumbaugh J, Liu X, Rabii R, Feng S, Misuno K, Messadi D, Hu S.

BMC Cancer. 2014 Mar 25;14:223. doi: 10.1186/1471-2407-14-223.

PMID:
24666435
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Metabolic requirements for the maintenance of self-renewing stem cells.

Ito K, Suda T.

Nat Rev Mol Cell Biol. 2014 Apr;15(4):243-56. doi: 10.1038/nrm3772. Review.

PMID:
24651542
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.

Kazi AA, Gilani RA, Schech AJ, Chumsri S, Sabnis G, Shah P, Goloubeva O, Kronsberg S, Brodie AH.

Breast Cancer Res. 2014 Jan 29;16(1):R15. doi: 10.1186/bcr3609.

PMID:
24472707
[PubMed - in process]
Free PMC Article
5.

Tumor glycolysis as a target for cancer therapy: progress and prospects.

Ganapathy-Kanniappan S, Geschwind JF.

Mol Cancer. 2013 Dec 3;12:152. doi: 10.1186/1476-4598-12-152. Review.

PMID:
24298908
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Linking vitamin B1 with cancer cell metabolism.

Zastre JA, Sweet RL, Hanberry BS, Ye S.

Cancer Metab. 2013 Jul 24;1(1):16. doi: 10.1186/2049-3002-1-16.

PMID:
24280319
[PubMed]
Free PMC Article
7.

Hypoxia-inducible factors: mediators of cancer progression; prognostic and therapeutic targets in soft tissue sarcomas.

Sadri N, Zhang PJ.

Cancers (Basel). 2013 Apr 2;5(2):320-33. doi: 10.3390/cancers5020320.

PMID:
24216979
[PubMed]
Free PMC Article
8.

Cross talk between Wnt/β-catenin and Irf8 in leukemia progression and drug resistance.

Scheller M, Schönheit J, Zimmermann K, Leser U, Rosenbauer F, Leutz A.

J Exp Med. 2013 Oct 21;210(11):2239-56. doi: 10.1084/jem.20130706. Epub 2013 Oct 7.

PMID:
24101380
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations.

Semenza GL.

J Clin Invest. 2013 Sep 3;123(9):3664-71. doi: 10.1172/JCI67230. Epub 2013 Sep 3. Review.

PMID:
23999440
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor era.

Comert M, Baran Y, Saydam G.

Am J Blood Res. 2013 Aug 19;3(3):191-200. eCollection 2013.

PMID:
23997982
[PubMed]
Free PMC Article
11.

The role of mitochondrial DNA damage and repair in the resistance of BCR/ABL-expressing cells to tyrosine kinase inhibitors.

Glowacki S, Synowiec E, Blasiak J.

Int J Mol Sci. 2013 Aug 7;14(8):16348-64. doi: 10.3390/ijms140816348.

PMID:
23965958
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells.

Wang J, Zhang X, Ma D, Lee WN, Xiao J, Zhao Y, Go VL, Wang Q, Yen Y, Recker R, Xiao GG.

Exp Hematol Oncol. 2013 Jul 27;2:18. doi: 10.1186/2162-3619-2-18. eCollection 2013.

PMID:
23890079
[PubMed]
Free PMC Article
13.

Role of SUMO-specific protease 2 in reprogramming cellular glucose metabolism.

Tang S, Huang G, Tong X, Xu L, Cai R, Li J, Zhou X, Song S, Huang C, Cheng J.

PLoS One. 2013 May 14;8(5):e63965. doi: 10.1371/journal.pone.0063965. Print 2013.

PMID:
23691130
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Nutrient sensing, metabolism, and cell growth control.

Yuan HX, Xiong Y, Guan KL.

Mol Cell. 2013 Feb 7;49(3):379-87. doi: 10.1016/j.molcel.2013.01.019. Review.

PMID:
23395268
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The bone marrow microenvironment as niche retreats for hematopoietic and leukemic stem cells.

Nwajei F, Konopleva M.

Adv Hematol. 2013;2013:953982. doi: 10.1155/2013/953982. Epub 2013 Jan 10.

PMID:
23365579
[PubMed]
Free PMC Article
16.

Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.

Shen YC, Ou DL, Hsu C, Lin KL, Chang CY, Lin CY, Liu SH, Cheng AL.

Br J Cancer. 2013 Jan 15;108(1):72-81. doi: 10.1038/bjc.2012.559. Epub 2012 Dec 20.

PMID:
23257894
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Computational modeling of the metabolic States regulated by the kinase akt.

Mosca E, Alfieri R, Maj C, Bevilacqua A, Canti G, Milanesi L.

Front Physiol. 2012 Nov 21;3:418. doi: 10.3389/fphys.2012.00418. eCollection 2012.

PMID:
23181020
[PubMed]
Free PMC Article
18.

Quantitative- and phospho-proteomic analysis of the yeast response to the tyrosine kinase inhibitor imatinib to pharmacoproteomics-guided drug line extension.

Dos Santos SC, Mira NP, Moreira AS, Sá-Correia I.

OMICS. 2012 Oct;16(10):537-51. doi: 10.1089/omi.2012.0012. Epub 2012 Jul 9.

PMID:
22775238
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

Ward PS, Thompson CB.

Cancer Cell. 2012 Mar 20;21(3):297-308. doi: 10.1016/j.ccr.2012.02.014. Review.

PMID:
22439925
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.

Semenza GL.

Trends Pharmacol Sci. 2012 Apr;33(4):207-14. doi: 10.1016/j.tips.2012.01.005. Epub 2012 Mar 6. Review.

PMID:
22398146
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk